- Home
- Labeler Index
- U.s. Pharmaceuticals
- 63539-502
- NDC Crossover: 63539-502 Xeljanz XR
NDC Crossover 63539-502 Xeljanz XR
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Tofacitinib Citrate
Explore similar products and medications to NDC 63539-502 Xeljanz XR a human prescription drug with other products crossover matching the same product name (Xeljanz XR) or generic name (Tofacitinib), and the same administration route (oral) or dosage form (tablet, extended release). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0069-0501 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-0502 | Xeljanz XR | Tofacitinib | Tablet, Film Coated, Extended Release | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1001 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1002 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
0069-1029 | Xeljanz | Tofacitinib | Solution | Oral | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
63539-012 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-016 | Xeljanz | Tofacitinib | Tablet, Film Coated | Oral | U.s. Pharmaceuticals | Human Prescription Drug |
63539-501 | Xeljanz XR | Tofacitinib | Tablet, Extended Release | Oral | U.s. Pharmaceuticals | Human Prescription Drug |